ASHG 2026 · Tier 2–3 Academic

Institut des Maladies Génétiques Imagine at ASHG 2026

Paris, France

Institut des Maladies Génétiques Imagine at ASHG 2026 in Montréal: 5 presentations (4 posters, 1 platform talk); 3 research groups.

5
presentations on the program
3
research groups identified
1
Reviewers’ Choice abstracts

Explore everyone at ASHG 2026 →

OrganizationASHG 2026 Attendance
Institut des Maladies Génétiques Imagine
Paris, France
2 PhD Students · 1 PI · 1 Staff Scientist
Genetics of Developmental Disorders Labinstitutimagine.org/en/jeanne-amiel-and-laurence-legeai-mallet-75
Wet lab~28 people
Uses zebrafish models with precise genome editing, primary cells and 2D/3D patient iPSCs. Studies rare developmental, skeletal, craniofacial and nervous-system disorders toward therapeutic development.
Funded by ANR, Fondation maladies rares +4 more
Mécénat des Mutuelles AXA, AXA Head and Heart Chair · since January 2023
“The “Head and Heart” Chair is supported by the Mécénat des Mutuelles AXA as main patron.”
ANR · active
“ANR - logo”
Fondation maladies rares · active
“Logo Fondation maladies rares”
+3 more on the lab page
Source: lab pages
7 platforms and techniques
Runs
Zebrafish disease models, 2D/3D patient iPSC-based models
Techniques
Precise genome editing, Animal models, Primary cells, Patient-derived iPSCs, 2D/3D iPSC cell-based models
Source: lab pages
No openings posted
Poster
Thu Oct 22
4:15 pm
De novo mutations of Asp630 in PLCB4 cause a novel syndrome comprising cardiovascular, pigmentation and neurodevelopmental defects
Mendelian Phenotypes
Collaborators: University of Calgary, Columbia University Irving Medical Center +6 more
Genotype-phenotype correlationsCardiovascular systemCharacterization of syndromesMendelian disorder
Poster
Fri Oct 23
2:30 pm
Clinical Bioinformatics Labinstitutimagine.org/en/RausellLab
Dry lab~18 people
Develops machine-learning methods for clinical, genomic, multi-omic, single-cell and exome/genome sequencing data. Supports genetic-variant interpretation, cell identification and rare-disease diagnosis.
17 papers since 2024
PFMG2025–integrating genomic medicine into the national healthcare system in France
The Lancet Regional Health - Europe, 2025
Smoking changes adaptive immunity with persistent effects
Nature, 2024
The phenotype of MEGF8-related Carpenter syndrome (CRPT2) is refined through the identification of eight new patients
European Journal of Human Genetics, 2024
Source: OpenAlex author A5005067371
Funded by Inserm, Tremplin Carnot Imagine +9 more
Inserm · active
“Inserm”
Tremplin Carnot Imagine · active
“Tremplin Carnot Imagine”
ANR · active
“ANR”
+8 more on the lab page
Source: lab pages
10 platforms and techniques
Analyzes
single-cell RNA sequencing, whole-exome sequencing, whole-genome sequencing
Techniques
machine learning, multivariate statistical modeling, gradient tree boosting, graph neural networks, random-walk diffusion, graph integration, functional variant annotation
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
PAGAN predicts digenic interactions by generalizing single-gene representations in biological networks
Artificial Intelligence and Machine Learning
Identification of disease genesBioinformaticsComputational toolsMachine learning
Génétique Ophtalmologique (GO)institutimagine.org/fr/jean-michel-rozet-192
Wet + dry lab~24 people
Studies hereditary retinal, optic-nerve and ocular-development disorders using OMIC analyses and next-generation sequencing. Uses clinical, molecular and genetic data from family cohorts.
17 papers since 2024
Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules
Science, 2024
Objectivizing issues in the diagnosis of complex rare diseases: lessons learned from testing existing diagnosis support systems on ciliopathies
BMC Medical Informatics and Decision Making, 2024
Structural Variant Disrupting the Expression of the Remote FOXC1 Gene in a Patient with Syndromic Complex Microphthalmia
International Journal of Molecular Sciences, 2024
Source: OpenAlex author A5068947363
Funded by PHRC
PHRC, Programme national de recherche clinique · active
“le groupe dirige un programme national de recherche clinique (PHRC)”
Source: lab pages
9 platforms and techniques
Analyzes
OMIC analyses, High-throughput sequencing, Whole-exome sequencing, Targeted exome sequencing, Whole-genome sequencing
Techniques
Genetic mapping, Positional cloning, Candidate-gene approach, Fibroblast biochemical studies
Source: lab pages
No openings posted
Talk
Sat Oct 24
9:45 am
Novel role of DDX41, a cancer-associated RNA helicase, in inherited retinal dystrophies
Decoding Sensory Diseases: Germline, Somatic, and Regulatory Mechanisms
Collaborators: Institute of Molecular and Clinical Ophthalmology Basel, University of Oxford +12 more
NeurodegenerationIdentification of disease genesVisual systemsModel organisms
1 more presenter — research group not yet identified

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Meeting Institut des Maladies Génétiques Imagine in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction